Dyadic International, Inc. (OTCMKTS:DYAI) Files An 8-K Other Events
Item 8.01. Other Events
On February 13, 2019, Dyadic International, Inc. (“Dyadic”) issued a press release announcing the Securities and Exchange Commission (the “SEC”) has declared the Company’s Registration Statement on Form 10-12G (the “Form 10”) effective as of February 12, 2019. In addition, the Company announced that it has filed an application to list its common stock on The NASDAQ Capital Markets Exchange (“NASDAQ”).
A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K.
DYADIC INTERNATIONAL INC Exhibit
EX-99.1 2 exhibit991.htm EXHIBIT 99.1 Exhibit Exhibit 99.1Dyadic Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQJupiter,…
To view the full exhibit click
About Dyadic International, Inc. (OTCMKTS:DYAI)
Dyadic International, Inc. (Dyadic) is a holding company. The Company is a global biotechnology company with operations in the United States and the Netherlands. Dyadic uses its technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceuticals and industrial enzymes industries. Its activities relating to selling enzymes focuses on utilizing its fungal strains and associated technologies. In particular, Dyadic uses its Trichoderma and C1 (Myceliopthora thermophila) fungal strains in the production of its industrial enzymes. Dyadic manufactures, purchases, and sells liquid and dry enzyme products to global customers for use within the animal feed, pulp and paper, starch and alcohol, food and brewing, textiles and biofuels industries. It is focused on biofuels and bio-based chemicals, biopharmaceuticals and industrial products.